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A Direct Comparison of Two 
Densely Sampled HIV Epidemics: 
The UK and Switzerland
Manon L. Ragonnet-Cronin1,*, Mohaned Shilaih2,3,*, Huldrych F. Günthard2,3, 
Emma B. Hodcroft1, Jürg Böni3, Esther Fearnhill4, David Dunn4, Sabine Yerly5, 
Thomas Klimkait6, Vincent Aubert7, Wan-Lin Yang2, Alison E. Brown8, Samantha J. Lycett1, 
Roger Kouyos2,3,* & Andrew J. Leigh Brown1,*
Phylogenetic clustering approaches can elucidate HIV transmission dynamics. Comparisons across 
countries are essential for evaluating public health policies. Here, we used a standardised approach 
to compare the UK HIV Drug Resistance Database and the Swiss HIV Cohort Study while maintaining 
data-protection requirements. Clusters were identified in subtype A1, B and C pol phylogenies. We 
generated degree distributions for each risk group and compared distributions between countries 
using Kolmogorov-Smirnov (KS) tests, Degree Distribution Quantification and Comparison (DDQC) 
and bootstrapping. We used logistic regression to predict cluster membership based on country, 
sampling date, risk group, ethnicity and sex. We analysed >8,000 Swiss and >30,000 UK subtype B 
sequences. At 4.5% genetic distance, the UK was more clustered and MSM and heterosexual degree 
distributions differed significantly by the KS test. The KS test is sensitive to variation in network scale, 
and jackknifing the UK MSM dataset to the size of the Swiss dataset removed the difference. Only 
heterosexuals varied based on the DDQC, due to UK male heterosexuals who clustered exclusively 
with MSM. Their removal eliminated this difference. In conclusion, the UK and Swiss HIV epidemics 
have similar underlying dynamics and observed differences in clustering are mainly due to different 
population sizes.
Despite huge advances in prevention and treatment, the global burden of HIV continues to rise and novel 
approaches are required to eliminate the virus. Phylogenetic analyses of HIV genetic sequences enable detailed 
reconstructions of historical and current HIV transmission. As such, phylogenetics can help identify populations 
at risk and better tailor public health interventions.
The UK and Switzerland have two of the most extensive HIV sequence databases in the world: the UK HIV 
Drug Resistance Database (UK HIV RDB) and the Swiss HIV Cohort Study (SHCS), which contain pol sequences 
from at least 60% of diagnosed patients within each country. These databases have allowed Switzerland and the 
UK to lead the way in population-level HIV research, including HIV phylogenetics. Phylogenetic analyses of HIV 
in these densely sampled epidemics have been used to estimate epidemic parameters including times between 
transmissions according to risk group1,2, crossover between risk groups3–5 and the relative contributions of local 
versus imported infections5.
HIV was introduced into UK men who have sex with men (MSM) around 19806, probably from the USA7. 
Until the early 1990 s the epidemic was dominated by the transmission of subtype B among MSM and people who 
inject drugs (PWID). Six large reconstructed MSM transmission chains reflect independent introductions. The 
MSM epidemic displayed exponential growth in the 1980 s then stabilised in the 1990 s but continues to be highly 
clustered8. In the 1990 s, cases among heterosexuals became more common9 and non-B subtypes increased10,11. 
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Within MSM clusters, 25% of transmissions occur within 6 months of infection2. Heterosexuals in the UK display 
far less clustering and slower epidemic dynamics: only 2% of transmissions occur within 6 months of infection1. 
Currently, 100,000 people are living with HIV (0.15% prevalence), one quarter of whom are unaware of their 
infection12. Highly Active Antiretroviral Therapy (HAART) became available to residents in 1996 and to all in 
2012. HIV positive people on successful treatment in the UK have normal life expectancy13.
Switzerland had the highest HIV prevalence in Europe in the 1980 s14. HIV initially spread among MSM and 
PWID15 with heterosexual transmission starting to play a role after the mid-1980 s. The number of new diagnoses 
declined in the 1990 s, owing to needle exchange, heightened awareness, wide-scale testing, and the introduction 
of HAART in 1996. The number of new HIV diagnoses in Switzerland has fluctuated since 2000 with no clear time 
trends. The MSM and PWID epidemics display limited overlap. The heterosexual subtype B epidemic appears to 
be reseeded by PWID, migration, and (to a limited extent) MSM, with the importance of PWID in driving new 
infections decreasing over time3,5,16 (less than 3 PWID infections per year in the last 5 years17). Meanwhile only 
25% of non-B infections arise within Swiss-specific clusters, indicating a growing role for immigration5.
One important focus of phylogenetic analyses is on clusters: groups of sequences more related to each other 
than to the rest of the tree. Clustered sequences represent epidemiologically linked infections with short durations 
of time between transmissions and thus clusters represent the leading edge of the epidemic. High clustering of 
sequences within a country indicates rapid transmission and a bias towards within-country transmission.
Despite the two countries sharing similar epidemic histories, separate analyses have suggested different struc-
tures of the two countries’ epidemics, including distinct proportions of clustered sequences. In the UK, 24%, 40% 
and 22% of patients infected with HIV-1 subtypes B17, A1 and C12, respectively, cluster, whereas the numbers for 
Switzerland are 55%, 21% and 16%3,5. Clearly these differences arise in part due to distinct cluster definitions: the 
SHCS defines a cluster as ≥ 10 sequences supported by > 80% bootstrap3, while the UK studies defined clusters by 
a genetic distance (GD) ≤ 4.5% and bootstrap ≥ 90%2. Variable cluster definitions are a common problem in the 
literature. Bootstraps from 70% to 99% are used, in combination with GD from 1.5% to 4.5%. Another reason for 
the disparity could be differences in sampling procedures. However it is also possible that the contact and trans-
mission processes between Switzerland and the UK differ. Given these observed differences, it is unclear to what 
extent findings from one country can be applied to the other, and more importantly whether results from either 
can be extended to other less densely sampled European epidemics.
Because access to data from national cohorts is subject to restrictions, and because analyses have been con-
ducted according to in-house bioinformatics pipelines, the differences between the two epidemics have never 
been elucidated. Here, we present an analysis conducted in parallel on the two epidemics using a standardised 
approach. We hypothesised that because of its geography, the Swiss epidemic might be more integrated into the 
European epidemic and less clustered because of unsampled links in Swiss transmission chains. Using the same 
cluster definition, we compared the cluster distributions (the number and sizes of clusters) of the two countries 
as an indicator of underlying epidemic dynamics. We determined whether clustering was affected by risk group 
and ethnicity and compared the degree distributions (the number of linked partners) of heterosexual, MSM and 
PWID to test whether differences between countries were down to any specific risk group. Finally, we tested 
whether the UK and Swiss epidemics intermingled with the same foreign countries through sequence analysis.
Results
Baseline demographics. HIV pol sequences were retrieved from the SHCS drug resistance database18 
(SHCS DRDB, 2014) and from the UK HIV RDB (sequences up to mid-2013). Closely related sequences were 
obtained from the Los Alamos National Laboratory (LANL) database as described in the Methods. In the final 
analyses, the Swiss datasets contained 1,374 subtype A1 sequences (435 Swiss, 939 LANL), 15,043 B (8,390 Swiss, 
6,653 LANL) and 1,571 C (419 Swiss, 1,152 LANL). The UK datasets comprised 4,421 A1 (2,507 UK, 1,914 
LANL), 38,863 B (31,450 UK, 7,413 LANL) and 22,027 C (15,815 UK, 6,212 LANL). The Swiss epidemic com-
prised more PWID, fewer heterosexuals and more patients of White ethnicity (Table 1). These differences were in 
part a result of the different subtype composition across the two countries, but even within subtype B there were 
notable differences, with proportionally more cases among heterosexuals and PWID in Switzerland.
In both countries individuals for whom sequence and epidemiological data were available broadly matched 
the characteristics of the HIV diagnosed population as a whole, in terms of risk group, sex, ethnicity and age 
distribution19,20. Swiss sequence dates go back to 1995 owing to retrospective sequencing of samples from the 
SHCS Bio-bank21.
Sex Female
UK CH
A1 B C A1 B C
1442 (57.5%) 2327 (7.4%) 3869 (62.2%) 269 (62%) 1812 (22%) 237 (57%)
Risk
MSM 170 (6.8%) 22157 (70.4%) 660 (4.2%) 21 (5%) 3914 (47%) 25 (6%)
HET 1718 (68.5%) 3399 (10.8%) 11893 (75.2%) 366 (84%) 2626 (31%) 357 (85%)
PWID 92 (3.7%) 873 (2.8%) 128 (0.8%) 12 (3%) 1553 (19%) 9 (2%)
Other/NA 527 (21%) 5021 (16%) 3134 (19.8%) 36 (8%) 287 (3%) 28 (7%)
Ethnicity White 494 (19.7%) 22724 (72.3%) 1724 (10.9%) 194 (45%) 7333 (87%) 118 (28%)
Total 2507 31450 15815 435 8390 419
Table 1.  Baseline demographics of the two datasets.
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Difference in clustering. Maximum likelihood phylogenetic trees were constructed and clusters were 
selected22 at a range of genetic distance (GD) and bootstrap thresholds. A significantly larger proportion of 
UK subtype B sequences clustered in the uncorrected analysis at all thresholds (Supplementary Table 1, Fig. 1). 
Concordantly, the UK was more clustered in the univariate analysis (Table 2) with odds for being in a cluster 4 
times higher at 4.5% GD. At 4.5% GD, subtypes C and A1 were also more clustered in the UK, but there was no 
significant difference at 1.5% GD. The subsequent analysis focused mainly on subtype B.
Because of the difference in sampling time distributions and demographics between the two subtype B data-
sets, we considered the logistic regression adjusting for those variables. More recent samples were much more 
likely to cluster than older samples (Table 3) and when the model was adjusted for sample date, the Swiss epi-
demic was more clustered than the UK epidemic at 1.5% GD. At 4.5% GD, clustering remained higher for the UK 
but the strength of the association was halved compared with the univariate model. The effect of risk group and 
ethnicity on clustering was consistent across the two countries, with MSM in both countries showing the highest 
propensity for clustering.
Degree Distributions. Degree distributions for each country and risk group were generated based on cluster 
size distributions and compositions. For example a cluster containing 3 heterosexuals is equivalent to 3 hetero-
sexuals each with degree 2. Statistical frameworks exist to formally compare degree distributions23–25 and include 
bootstrapping to simulate the effect of the sampling process and test the robustness of conclusions. Degree dis-
tributions for the populations as a whole and for each risk group were compared using the Kolmogorov-Smirnov 
(KS) tests24 and the Degree Distribution Quantification and Comparison (DDQC) algorithm23. Based on the KS 
test, there was no difference between the two countries at 1.5% GD. At 4.5% GD, distributions differed signifi-
cantly for HET, MSM and the population as a whole, but not for PWID (Supplementary Table 2). The difference 
appeared to be driven by the longer tail of the UK distributions (Fig. 2), indicating the existence of larger clusters 
in the UK. The UK epidemic thus comprised not only a higher proportion of sequences in clusters, but also clus-
ters were larger.
Because the KS test is sensitive to network size, we applied the DDQC, which is robust to differences in scale. 
The DDQC measures the distance between networks based on features extracted from their degree distributions. 
However, it does not indicate whether distances calculated are significant or not. In order to generate null dis-
tributions, the UK and Swiss degree distributions were compared to themselves through bootstrapping. The UK 
and Swiss degree distributions were each bootstrapped 100 times to simulate the effect of sampling (see Methods) 
and the DDQC distance calculated between the true data and each bootstrap replicate (Fig. 3). Between country 
DDQC values were considered significant if they exceeded the 95% percentile of the within country DDQC 
Figure 1. Proportion of UK (pink) and Swiss (blue) sequences in clusters at different genetic distance (1.5% 
and 4.5%) and bootstrap (70%, 80%, 90%, 95%) thresholds. CH - Switzerland.
Bootstrap
Genetic 
Distance Covariates OR 2.5% 97.5%
0.7 0.015 UK 1.316 1.243 1.394
0.8 0.015 UK 1.335 1.258 1.418
0.9 0.015 UK 1.396 1.308 1.492
0.95 0.015 UK 1.444 1.345 1.551
0.7 0.045 UK 5.001 4.745 5.272
0.8 0.045 UK 4.119 3.904 4.347
0.9 0.045 UK 3.942 3.722 4.176
0.95 0.045 UK 3.176 2.986 3.381
Table 2.  Unadjusted logistic regression for the comparison of the degree of patients clustering between the 
UK and Switzerland (Subtype B). OR: odds-ratio.
www.nature.com/scientificreports/
4Scientific RepoRts | 6:32251 | DOI: 10.1038/srep32251
values (one-sided test). The DDQC distance was higher than expected only for heterosexuals at 4.5% GD (95th 
percentile DDQC = 0.97, observed HET DDQC = 1.22).
We hypothesised that the difference highlighted by the KS test at 4.5% might be the result of a difference in 
scale between the two epidemics. The UK population (and the HIV+ population) is much larger than that of 
Switzerland and so the pool of partners available is bigger. To examine the effect of epidemic size on clustering 
and degree distributions, we down-sampled the UK subtype B datasets to match the size of the Swiss datasets. In 
parallel, the Swiss datasets were bootstrap sampled with replacement. When these equal-sized resampled datasets 
were compared, the UK and Swiss degree distributions overlapped for the population as a whole and for the MSM 
population, but not for heterosexuals (Fig. 4).
In the true and the jack-knife sampled UK heterosexual population, we observed male heterosexuals with 
high degree (> 20) not present in the Swiss data (Fig. 4). The largest exclusively heterosexual cluster in the UK 
comprised 27 individuals (bootstrap = 0.9, GD = 4.5%); all heterosexuals with higher degree were in clusters 
dominated by MSM. When we dropped heterosexuals with degree > 26 from the UK sample (125 individuals out 
of a total of 1556 heterosexuals), the DDQC distance between the two networks fell within its null distribution 
(DDQC = 0.17, Fig. 3).
Cross border transmission. We investigated intermingling between national and foreign sequences by 
removing the 80% national criterion. We used a tight GD threshold (1.5%, 70% bootstrap) to capture close trans-
mission partners. At this threshold, Swiss sequences clustered with 162 non-Swiss sequences and UK sequences 
clustered with 353 non-UK sequences. For Switzerland, Western European countries provided over 75% of 
the links. For the UK, 50% of close links were with other European countries and 20% originated from other 
Anglophone countries: Australia, Canada and the USA (Supplementary Figure 1).
Discussion
The aim of this study was to compare epidemic dynamics between the two most densely sampled HIV epidemics, 
the UK and Switzerland, while adhering to data governance procedures and privacy protection requirements. We 
found that the fraction of sequences in transmission clusters was similar between the UK and Switzerland for a 
strict GD threshold (1.5%) but that they differed at a more relaxed GD threshold (4.5%). This suggests that the 
two epidemics resemble each other at a micro-level but differ at a macro-level. Because a statistical framework 
for comparing cluster distributions directly is lacking, we generated degree distributions based on cluster sizes 
and compared them through formal statistical tests: the KS test, the DDQC and bootstrapping. Based on the 
KS test, there were differences between the UK and Swiss subtype B degree distributions at 4.5% GD. However, 
downsampling the UK dataset to the size of the Swiss dataset rendered this difference insignificant in MSM and 
the population as a whole, but not heterosexuals (Fig. 4). In parallel, only heterosexuals showed a significant dif-
ference based on the DDQC test, which corrects for network size.
The degree distribution of UK heterosexuals had a long tail representing male heterosexuals clustered exclu-
sively with MSM. Previous UK analyses have demonstrated that a proportion of self-reported male heterosexuals 
are likely to have been infected through sex with men26, which appears to be the case here. When those high 
degree heterosexuals were removed from the dataset, the UK and Swiss no longer differed. Male heterosexuals 
who have sex with men are likely to also have sex with women and provide a bridge between MSM and heterosex-
ual epidemics. This is a likely route for the spread of non-B subtypes among MSM in the UK4. More detailed anal-
yses of the Swiss epidemic have found little overlap between the MSM and HET epidemics3; however, the Swiss 
heterosexual with the highest degree was similarly part of a HET/MSM cluster comprising 36 individuals, while 
Bootstrap
Genetic 
Distance Covariates OR 2.5% 97.5%
0.7 0.015
UK 0.66 0.617 0.705
Sample year 1.138 1.131 1.145
0.8 0.015
UK 0.665 0.621 0.713
Sample year 1.142 1.134 1.149
0.9 0.015
UK 0.694 0.645 0.749
Sample year 1.146 1.138 1.154
0.95 0.015
UK 0.706 0.651 0.765
Sample year 1.153 1.144 1.162
0.7 0.045
UK 2.692 2.538 2.856
Sample year 1.134 1.128 1.14
0.8 0.045
UK 2.12 1.996 2.252
Sample year 1.145 1.139 1.151
0.9 0.045
UK 1.968 1.846 2.099
Sample year 1.156 1.15 1.163
0.95 0.045
UK 1.551 1.448 1.662
Sample year 1.161 1.154 1.168
Table 3.  Logistic regression for the comparison of the degree of patients clustering between the UK and 
Switzerland, corrected for sample year (Subtype B). OR: odds-ratio.
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the largest exclusively heterosexual cluster contained only 9. In fact, 47% of UK and 38% of Swiss heterosexuals 
were in HET/MSM clusters. The present analysis cannot determine whether bridging is more common in the UK 
or whether risk group classification is assessed more thoroughly in Switzerland.
There was more overlap between PWID and heterosexuals in Switzerland than in the UK (23% vs 12%), but 
the difference in PWID degree distributions was not significant. Although this could be due to sample size, the 
stemming of the heterosexual epidemic through PWID in Switzerland is likely to be an old process3 while the 
bridging between HET and MSM in the UK is ongoing4,26.
Our findings were consistent across bootstrap thresholds. At 1.5% GD, we found no difference between the 
degree distributions of the Swiss and UK epidemics. At tight thresholds mostly pairs and recently infected patients 
are captured and these groupings are similar across the two countries. At 4.5% GD, the UK was more clustered and 
so the UK HIV RDB is more likely to capture larger transmission chains. However, the downsampled UK epidemic 
degree distribution overlapped with the Swiss degree distribution. While the proportion of clustered individuals in 
the UK is higher, the difference is seemingly due to the UK greater epidemic size rather than because of differences 
Figure 2. Degree distributions of the UK (pink) and Swiss (blue) subtype B epidemics. MSM - men who 
have sex with men, HET - heterosexuals. Cluster definition was: genetic distance = 4.5% and bootstrap = 90%. 
Note that the proportion of individuals of each degree is shown rather than the absolute number of individuals 
of each degree. The number of clustered individuals was much larger in the UK than in Switzerland.
Figure 3. DDQC distances within and between countries. DDQC – Degree Distribution Quantification and 
Comparison, CH - Switzerland, MSM - men who have sex with men, HET - heterosexuals. PWID – people 
who inject drugs. Cluster definition was: genetic distance = 4.5% and bootstrap = 90%. In order to generate 
null distributions of the expected values for the DDQC, we bootstrapped the Swiss and UK distributions and 
calculated DDQC values comparing the original datasets to their bootstrap samples (in blue and pink). The top 
of the coloured bars represent the mean distance of within country comparisons and the whiskers represent 
the 95% percentiles. The DDQC distance was then calculated between the UK and Swiss degree distributions 
(black triangles). The distance between countries was considered significant if it exceeded the 95% percentile 
from the simulated values, which was the case only for HET at 4.5% GD (indicated by *). When we removed 
heterosexuals who were likely to have been infected through sex with men from the UK dataset, the DDQC 
distance between the UK and Swiss HET degree distributions fell within the simulated null distribution (orange 
triangle).
www.nature.com/scientificreports/
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in contact or transmission processes. Both countries are similarly integrated into global unsampled epidemics, and 
this study underlines the importance of HIV public health interventions at the European and global levels.
Transmission between European countries has been analysed in more depth elsewhere27. In agreement 
with that analysis, we found Spain to be a major mixing partner for both Switzerland and the UK. Germany 
and the Czech Republic were also identified as significant. We found increased linkage between the UK and 
other Anglophone countries. In Switzerland strong segregation has been observed between German and 
French-speaking regions3 and this language-dependency of HIV transmission warrants investigation at the global 
scale.
Both countries have noted the subtype diversification of their respective epidemics9,28, yet the difference in 
size between the UK and Swiss subtype A1 and C datasets (18,000 vs 900, respectively) rendered a comparison 
meaningless. In Switzerland fewer than 25% of non-B infections were acquired in the country5, whereas in the 
UK over 50% of infections in individuals born abroad are thought to have occurred in the UK11. Local non-B 
non-heterosexual transmission appears far more extensive in the UK4.
Although degree distributions are a blunt tool for elucidating the dynamics of an epidemic29, they allowed 
us to apply statistically robust methods to compare the two epidemics without the need for exchanging sensitive 
data. Sequences from national databases were never exchanged and while this precluded a combined phylogenetic 
analysis of UK and Swiss sequences, one of the strengths of the study stems from undertaking such an analysis 
without compromising patient privacy. A second issue, the distributions of sample dates differing between the 
two cohorts, arose because the SHCS has conducted extensive retrospective sequencing on patients diagnosed 
early on in the epidemic and for whom samples had been stored. The SHCS coverage of older samples explains 
in part the lower clustering observed in Switzerland. However, clustering remained significantly higher in the 
UK at 4.5% GD after sample date was adjusted for. Thirdly, international comparisons were based on the LANL 
database which is in essence a large-scale convenience sample and not necessarily representative. We suggest the 
apparently important contribution of the Czech Republic to both epidemics may arise from recent submission of 
large numbers of sequences from that country.
In conclusion, we showed that apparent major differences in clustering patterns between the UK and 
Switzerland subtype B epidemics can be explained for the most part by differences in size and sampling time. 
This is the first study leveraging the vast amounts of data available in multiple national HIV databases. We made 
use of data without breaching data governance procedures and highlighted that transmission trends in these two 
countries are driven by similar underlying factors. From a methodological perspective, our study highlights the 
importance of using the same cluster-detection algorithm and correcting for demographic factors when compar-
ing clustering patterns across settings.
Methods
Data. Switzerland. 9,232 HIV pol sequences were retrieved from the SHCS DRDB. The SHCS DRDB aggre-
gates all HIV resistance tests for patients of the SHCS. SmartGene is responsible for data storage and management 
(http://www.smartgene.com). The DRDB is part of the SHCS, which is an ongoing national clinical cohort of 
HIV patients aged 16 and above with biannual follow up (http://www.shcs.ch)20. Sequences were assigned sub-
types using REGA30,31; subtypes B (91%), A1 (5%), and C (5%) were analysed. The SHCS has been approved by 
the ethics committees of all participating institutions, and written, informed consent has been obtained from 
participants.
UK. 63,065 HIV pol sequences were obtained from the UK HIV RDB (http://www.hivrdb.org). Sequences cover 
protease and 900 bases of reverse transcriptase. After age, sex, risk group and ethnicity were attached, the data 
Figure 4. Jack-knife and bootstrap sampled degree distributions of the UK (pink) and Swiss (blue) 
epidemics. UK subtype B degree distribution for men who have sex with men (MSM), heterosexuals (HET) and 
the population as a whole (all) were jack-knife sampled 100 times to match the size of the Swiss epidemics (in 
light pink). The Swiss epidemic was bootstrapped 100 times to its full size (in light blue). Degree distributions 
are shown on a double-logged scale. Samples overlapped for MSM and the dataset as a whole, but not for HET. 
Where Swiss replicates cannot be seen they are covered by the UK replicates.
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were anonymised and delinked. Subtypes were assigned using SCUEAL32 and REGA30,31. The three most com-
mon subtypes were B (48.6%), C (24.4%), and A1 (4.0%). Ethical approval was given by the London Multicentre 
Research Ethics Committee (MREC/01/2/10; 5 April 2001).
As submission of the UK and Swiss sequence datasets to public databases would permit transmission network 
identification and thus risk breaching patient confidentiality, we have followed earlier practice3,33. A random 
sample of 10% of each subtype and country has been submitted to Genbank (accession numbers available in 
supplementary material).
Background sequences. All pol (HXB2 positions 2253–3870) sequences of HIV subtype A1, B, and C longer than 
900 bases were retrieved from LANL (January 2014). To limit the size of alignments, the ten closest sequences 
to each of the local (UK and Swiss) sequences were selected using Viroblast34. For this step, UK sequences were 
removed from LANL alignments before the UK Viroblast run, and Swiss LANL sequences were removed before 
the Swiss run.
Only the earliest available sequence for each individual was used. All sequences were stripped of 44 sites asso-
ciated with drug resistance based on the 2013 International AIDS Society list35.
Tree Building and Cluster Picking. Duplicate sequences were removed. Maximum likelihood phyloge-
netic trees were constructed for each country and subtype separately (six trees in total) using FastTree v2.036 with 
100 bootstraps. Initially clusters were selected for further analysis if they were supported by bootstrap thresholds 
of 70%, 80%, 90% and 95% and maximum GD of 1.5% or 4.5% (8 thresholds total)22. Of the initially identified 
clusters, those in the Swiss trees were further selected to contain at least 80% SHCS sequences, and clusters in 
the UK trees at least 80% UK sequences. In a separate analysis, we examined all clusters with at least one UK or 
Swiss sequence (within the respective datasets) to investigate mixing between national and foreign sequences. The 
automated pipeline included analysis with the Cluster Picker and Cluster Matcher22 as well as processing through 
python and R scripts (available upon request). The Cluster Picker was upgraded to recognise IUPAC nucleotide 
ambiguity codes as matches (version available upon request from the authors), increasing clustering by around 
15% in both datasets.
From the Cluster Picker and Cluster Matcher output files, we generated degree distributions (the number of 
links for each node). As files contained risk group composition for each cluster, it was possible to break down 
degree distribution by risk group. Nodes were sampled with replacement from the network with information 
on their cluster membership. Nodes sampled with the same cluster membership were linked together in each 
bootstrapped network, so that clusters sometimes increased in size, sometimes decreased in size or otherwise 
disappeared, and degree distribution was re-estimated each time. Jack-knife resampling where the number of 
nodes sampled was smaller than the full network size was also performed.
Statistical analysis. The number of sequences clustering at different thresholds between the two epidemics 
was compared using Fisher’s exact test with Bonferroni correction (24 comparisons across clustering thresholds 
and subtypes). Degree distributions were compared using the KS test24 and the DDQC algorithm23. The KS test is 
a nonparametric test which compares the cumulative distribution of two samples to estimate whether they have 
been drawn from the same distribution and is frequently used to compare degree distributions25. The DDQC was 
developed specifically to compare degree distributions and corrects for differences in population size while the 
KS test does not. The DDQC extracts a vector of eight values from degree distributions for comparison. In brief, 
the range of node degrees is divided into eight regions based on the minimum, maximum, mean and standard 
deviation of the degree distribution. The probability of the degree of any node being contained within each inter-
val is calculated. The distance between two networks is the sum of the absolute differences for each of the eight 
features extracted.
The UK subtype B dataset used here was 3.75 times larger than the Swiss dataset; the UK MSM dataset was 5.7 
times larger and the UK heterosexual dataset was 1.3 times larger (Table 1). To investigate the effect of the differ-
ence in size of the pool of possible infectors, the UK dataset was jack-knife sampled to the size of the Swiss dataset. 
One hundred jack-knife replicates were generated, and in each replicate the degree distribution was re-estimated 
based on the links present in the sample.
A logistic regression model was used to characterise the factors influencing clustering in the two countries. 
The model was applied with cluster membership as the outcome variable and with the country of origin (UK 
or Switzerland) as the main exposure variable. Sampling dates, risk group, sex, and ethnicity were adjusted for. 
Statistical analyses were conducted in R37.
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